News
The Latest
Hormonal Contraception Does Not Increase HIV Risk, Study Finds
No meaningful difference was found in either injectable or implant birth control when compared to an IUD.
This Week in HIV Research: One Step at a Time
June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.
HIV Advocacy Group Spars With Express Scripts Over HIV Drug Formulary Changes
Starting July 1, some HIV meds that are widely used will be excluded from their list.
HIV Testing Among Black Gay and Bisexual Men Remains 'Suboptimal,' Study Finds
Black men who have sex with men test in high numbers over a lifetime, but not frequently or recently.
Government Panel Finds PrEP Is Effective, Must Be Available Free of Cost to Patients
The US Preventive Services Task Force released its final ruling in JAMA.
This Week in HIV Research: The Racism of Perceived Risk
June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.
Trump Administration Ends Fetal Tissue Research, Cancels Major HIV Grant
Advocates say the move is more politics than science.
CDC Study Reinforces the Importance of Annual STI Testing Among MSM
Rectal and throat tests matter too, and providers should be recommending them.
This Week in HIV Research: Matters of the Heart
May 30, 2019: Myocardial infarction risk among people with HIV; dolutegravir vs. efavirenz; a new way to estimate date of seroconversion; identifying people at imminent risk for disengagement from care.
FDA Approves First Throat and Rectal Tests for Detecting Chlamydia and Gonorrhea
These two tests make it easier to diagnose sexually transmitted infections that often go untreated.